Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FS24J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,542
Award facts
- Contract value 100% obligated
- $34,542.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,542.36 to AmerSourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance at AmerSourceBergen's Conshohocken, Pennsylvania facility. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe eczema, asthma, and other allergic conditions, making this delivery order part of the broader pharmaceutical supply chain supporting military treatment facilities and veterans' healthcare programs. AmerSourceBergen's substantial IDC with DLA reflects the company's established capability to supply a wide range of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This non-competitive delivery order demonstrates the efficient utilization of the existing IDC vehicle to fulfill specific pharmaceutical requirements for federal medical systems.
Quick answers
Who was awarded contract SPE2DR26FS24J?
SPE2DR26FS24J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FS24J worth?
The government has obligated $34,542 on SPE2DR26FS24J.
Is contract SPE2DR26FS24J an order under another contract?
Yes. SPE2DR26FS24J is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS24J competed?
The extent of competition for SPE2DR26FS24J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award